Fresh Rounds

NK-One Therapeutics, Inc. funding

NK-One Therapeutics, Inc., a biotechnology company based in Wayne, PA (founded 2026), filed a Form D with the SEC on April 27, 2026 and reported $290K raised of a $310K offering.

Amount raised$290K
Offering size$310K
Filed with the SECApril 27, 2026
First saleMarch 4, 2026
IndustryBiotechnology
SecuritiesSecurity to be acquired on exercise
LocationWayne, PA
Founded2026
Entity typeCorporation
Investors so far7
Minimum investment—
Revenue rangeDecline to Disclose

Other health care rounds in Pennsylvania